PODCAST: David Diamond, PhD discusses Forgotten Baby Syndrome

The federal agency provided BioCryst Pharmaceuticals a target action date of September 12, 2025 for potential approval of berotralstat (ORLADEYO).

According to the agency, it is seeking public input to "determine whether existing nutrient requirements should be revised based on latest scientific data."

Maternal avocado consumption during pregnancy was linked to significantly lower odds of infant food allergy at 12 months.

The in vivo hematopoietic stem cell-directed therapy received rare pediatric disease and orphan drug designations earlier this year.